ArticleHaematologica2024
A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia.
Kevin Quann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it